|
Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.3620 EUR | 0.00% |
|
0.00% | +21.68% |
| 07-01 | Nicox Submits NCX 470 New Drug Application In The United States | CI |
| 07-01 | Nicox files U.S. marketing approval application |  |
Evolution of the Average Target: Nicox SA
Evolution of the Target Price: Nicox SA
Changes in Analyst Recommendations: Nicox SA
16f4adb9a0e183713.EEFjal8QBUR7yFFI1VCwMziNZ8swTDSM3rOyMT8HcWk.Yi4TU2thaA9ImDkY5GPnYnrcX4B4NHfviOHDHG0xRSNYAFMAKENPCyuuEA~af267d8313979b0d498c49eef06ece0c
| Consensus | Analysts' recommendations evolution (4 months) | Financial estimates divergence | Analysts' Target price divergence | Objective/dr gap | ||
|---|---|---|---|---|---|---|
 | +2.56% | |||||
| +4.13% | |||||
| -15.63% | |||||
| +69.18% | |||||
| - | - | -25.92% | |||
| +80.42% | |||||
| +33.04% | |||||
| - | - | - | |||
| Average | +21.11% | |||||
| Weighted average by Cap. | +3.70% |
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3770EUR
Average target price
1.000EUR
Spread / Average Target
+165.25%
High Price Target
1.000EUR
Spread / Highest target
+165.25%
Low Price Target
1.000EUR
Spread / Lowest Target
+165.25%
Analyst Consensus Detail
Consensus revision (last 18 months)
SellBuy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.3770EUR
Average target price
1.000EUR
Spread / Average Target
+165.25%
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- ALCOX Stock
- NXOA Stock
- Consensus Nicox SA
Select your edition
All financial news and data tailored to specific country editions
